Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2016 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Edelweiss Large & Mid Cap Fund |
|---|---|
| 28 Nov 2016 | ₹100.00 |
| 20 Sep 2017 | ₹119.60 |
| 13 Jul 2018 | ₹125.52 |
| 05 May 2019 | ₹117.48 |
| 25 Feb 2020 | ₹130.44 |
| 17 Dec 2020 | ₹123.44 |
| 09 Oct 2021 | ₹161.91 |
| 01 Aug 2022 | ₹153.59 |
| 24 May 2023 | ₹163.71 |
| 15 Mar 2024 | ₹211.76 |
| 05 Jan 2025 | ₹267.65 |
| 28 Oct 2025 | ₹273.48 |
| 20 Aug 2026 | ₹286.73 |
| Metric | Edelweiss · Direct · IDCW NAV ₹42.57 Very High risk ★★★★☆ | Category median Large & Mid Cap Fund · 35 funds |
|---|---|---|
| +7.44% | +4.31% | |
| +16.81% | +12.18% | |
| +13.22% | +12.13% | |
| — | +9.85% | |
| +11.44% | +11.44% | |
| +14.62% | — | |
| +12.11% | +13.24% | |
| +12.30% | +12.72% | |
| — | +11.19% | |
| Risk | ||
| 15.11% | 15.59% | |
| 0.68 | 0.20 | |
| 0.93 | 0.26 | |
| -42.10% | -38.41% | |
| Nifty Midcap 150 | — | |
| +0.72% | -3.79% | |
| 0.83 | 0.85 | |
| 85.8% | 81.7% | |
| 77.5% | 93.5% | |
| 0.68% | 1.06% | |
| ₹63.87Cr | ₹3,576Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 36% | 40% | |
| Trideep Bhattacharya · 4.7y | — | |
| 28 Nov 2016 | — | |
| 87 | — | |
| 23.4% | — | |
| 0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.